Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply

Affiliations

¹ Department of Experimental and Clinical Medicine and Department of Oncology, Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy.

Editorial

Anna Linda Zignego et al. Aliment Pharmacol Ther. 2018 Oct.

. 2018 Oct;48(7):772-773.

doi: 10.1111/apt.14936.

¹ Department of Experimental and Clinical Medicine and Department of Oncology, Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy.

No abstract available

Comment on

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.
Gragnani L, Cerretelli G, Lorini S, Steidl C, Giovannelli A, Monti M, Petraccia L, Sadalla S, Urraro T, Caini P, Xheka A, Simone A, Arena U, Matucci-Cerinic M, Vergani D, Laffi G, Zignego AL. Gragnani L, et al. Aliment Pharmacol Ther. 2018 Aug;48(4):440-450. doi: 10.1111/apt.14845. Epub 2018 Jun 28. Aliment Pharmacol Ther. 2018. PMID: 29952013 Clinical Trial.
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia.
Atsukawa M, Tsubota A. Atsukawa M, et al. Aliment Pharmacol Ther. 2018 Oct;48(7):770-771. doi: 10.1111/apt.14899. Aliment Pharmacol Ther. 2018. PMID: 30246309 No abstract available.